Spherix Announces New Agreements to Develop and Market D-tagatose Thu, 02 May, 2013 07:58 PM PDT TYSONS CORNER, VA--(Marketwired - May 2, 2013) - Spherix Incorporated ( NASDAQ : SPEX ) -- an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, today announced the signing of a memorandum of understanding (MOU) with ChromaDex ( OTCQB : CDXC ) to extend the comm... Continue reading | | Aridhia announces Pivotal deal Thu, 02 May, 2013 07:32 PM PDT HEALTH analytics firm Aridhia has announced a partnership with California-based software company Pivotal, creating a new technology platform to improve treatments for chronic conditions such as cancer and diabetes. Continue reading | | |
No comments:
Post a Comment